RESTATED SENIOR SECURED CONVERTIBLE PROMISSORY NOTEConvertible Security Agreement • April 24th, 2017 • Protea Biosciences Group, Inc. • Pharmaceutical preparations • New York
Contract Type FiledApril 24th, 2017 Company Industry JurisdictionTHIS RESTATED SENIOR SECURED CONVERTIBLE PROMISSORY NOTE is issued pursuant to Section 3(a)(9) of the Securities Act of 1933, as amended, and is issued in exchange for a prior $720,000 10% OID original principal amount senior secured promissory note of PROTEA BIOSCIENCES GROUP, INC., a Delaware corporation, (the “Company”), having its principal place of business at 1311 Pineview Drive, Suite 501, Morgantown, WV 26505, that was issued to GRQ CONSULTANTS, INC. 401k on September 2, 2016 (the “Original Note”).
ContractWarrant Agreement • April 24th, 2017 • Protea Biosciences Group, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledApril 24th, 2017 Company Industry JurisdictionTHIS WARRANT AND THE SECURITIES UNDERLYING THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”) AND MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, ASSIGNED, PLEDGED, OR HYPOTHECATED IN THE ABSENCE OF SUCH REGISTRATION OR AN EXEMPTION THEREFROM UNDER SUCH SECURITIES ACT, ANY APPLICABLE STATE SECURITIES LAWS AND THE RULES AND REGULATIONS THEREUNDER.
GUARANTY AGREEMENTGuaranty Agreement • April 24th, 2017 • Protea Biosciences Group, Inc. • Pharmaceutical preparations • West Virginia
Contract Type FiledApril 24th, 2017 Company Industry JurisdictionTHIS GUARANTY AGREEMENT (this “Guaranty”), dated as of April __, 2017, by PROTEA BIOSCIENCES, INC., a Delaware corporation (the “Guarantor”) in favor of SUMMIT RESOURCES, INC. a West Virginia corporation (the “Lender”), or its registered assigns.
SECURITY AGREEMENTSecurity Agreement • April 24th, 2017 • Protea Biosciences Group, Inc. • Pharmaceutical preparations • West Virginia
Contract Type FiledApril 24th, 2017 Company Industry JurisdictionThis SECURITY AGREEMENT, dated as of April __, 2017 (as amended, supplemented or otherwise modified from time to time in accordance with the provisions hereof, this "Agreement"), made by and among (A) PROTEA BIOSCIENCES GROUP, INC.., a Delaware corporation (“PRGB” or the “Company”), (B) PROTEA BIOSCIENCES, INC., a Delaware corporation (“Protea” and individually and collectively, with the Company, the "Debtors"), and (C) SUMMIT RESOURCES, INC., a West Virginia corporation (“Summit”) or its designated assignees (together with Summit, the "Secured Party").
EXCHANGE AGREEMENTExchange Agreement • April 24th, 2017 • Protea Biosciences Group, Inc. • Pharmaceutical preparations • New York
Contract Type FiledApril 24th, 2017 Company Industry JurisdictionTHIS EXCHANGE AGREEMENT (the “Agreement”), dated April 17, 2017, but deemed to be effective as of March 31, 2017 (the “Effective Date”), is made by and between PROTEA BIOSCIENCES GROUP, INC., a Delaware corporation (“Company”), and GRQ CONSULTANTS, INC. 401(k) (“GRQ” or “Holder”), as a holder of a 10% OID senior secured promissory note of the Company in $720,000 original principal amount dated September 8, 2016 (the “Original Note”).